Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
10 pending office actions • 10 clients • 10 examiners • 9 art units • 0 of 10 (0%) have an AI response strategy ready • 57 patents granted in the last 365 days
Birchwood IP- CHK001 operates in the Biotechnology & Pharmaceuticals field with 498 career applications. The firm has achieved a resolved allowance rate of 94.33 percent. Currently, the firm has 6 pending office actions, which represent its active workload relative to its 498 career applications.
The firm's efficiency is reflected in an average of 1.01 office actions per allowance. This 1.01 average indicates a direct prosecution strategy. For practitioners, the 94.33 percent resolved allowance rate and the 1.01 office actions per allowance metric highlight the firm's performance in the Biotechnology & Pharmaceuticals sector. The 498 career applications provide a history of results, and the 6 pending office actions show the firm's current activity in securing patent grants. The 1.01 office actions per allowance figure suggests that many applications reach resolution with minimal examiner interaction, providing a benchmark for expected prosecution timelines.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 3 (30%) |
| §102 only | 1 (10%) |
| Multi-statute (no §101) | 5 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COLLIER, JAMESON D | 1 | 54.2% | +47.0% |
| BAKER, LORI LYNN | 1 | 78.5% | +6.6% |
| MCFARLAND, KATHLEEN MAVOURNEEN | 1 | 59.4% | +13.2% |
| GROOMS, NOA WILLIAM FRAN | 1 | 75.0% | +0.0% |
| BETIT, JACOB F | 1 | 33.9% | +17.0% |
| LU, JIONG-PING | 1 | 83.6% | +7.8% |
| GILLETT, JENNIFER ANN | 1 | 29.6% | +37.7% |
| MURESAN, ANA Z | 1 | 75.0% | +31.3% |
| JADHAO, SAMADHAN JAISING | 1 | 46.9% | +46.2% |
| PETRASH, HILARY ANN | 1 | 64.5% | +51.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294174 | CHEMICAL-MECHANICAL COMBINED MACHINING METHOD FOR SILICON CARBIDE SURFACE | LU, JIONG-PING | 26d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17681855 | Chimeric Antigen Receptor Targeting CD22 and CD19 and Application thereof | PETRASH, HILARY ANN | 19d |
| 18275226 | S-RBD Trimer Protein Vaccine for Novel Coronavirus and Preparation Method and Application Therefor | JADHAO, SAMADHAN JAISING | 47d |
| 19515421 | SHOE SOLE WITH GRAPHENE PROPULSION PLATE | COLLIER, JAMESON D | — |
| 18950225 | FOLDABLE PROTECTIVE COVER | MCFARLAND, KATHLEEN MAVOURNEEN | — |
| 18704949 | LUMINESCENT MATERIAL AND MINI-LED DEVICE PREPARED USING LUMINESCENT MATERIAL | GROOMS, NOA WILLIAM FRAN | — |
| 18288197 | SUPER-SOFT COMPOSITE WIPING NON-WOVEN FABRIC AND MANUFACTURING METHOD THEREFOR | GILLETT, JENNIFER ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18434764 | BEVERAGE CONTAINER AND COVER UNIT | BETIT, JACOB F | 324d overdue |
| 17681855 | Chimeric Antigen Receptor Targeting CD22 and CD19 and Application thereof | PETRASH, HILARY ANN | 19d |
| 18275226 | S-RBD Trimer Protein Vaccine for Novel Coronavirus and Preparation Method and Application Therefor | JADHAO, SAMADHAN JAISING | 47d |
| 19515421 | SHOE SOLE WITH GRAPHENE PROPULSION PLATE | COLLIER, JAMESON D | — |
| 18950225 | FOLDABLE PROTECTIVE COVER | MCFARLAND, KATHLEEN MAVOURNEEN | — |
| 18288197 | SUPER-SOFT COMPOSITE WIPING NON-WOVEN FABRIC AND MANUFACTURING METHOD THEREFOR | GILLETT, JENNIFER ANN | — |
| 17610458 | KETTLE-TYPE CONTINUOUS PRODUCTION METHOD FOR GLYCINE | MURESAN, ANA Z | — |
| Art Unit | Apps |
|---|---|
| 3732 | 1 |
| 3754 | 1 |
| 1734 | 1 |
| 3735 | 1 |
| 1713 | 1 |
| 1789 | 1 |
| 1692 | 1 |
| 1672 | 1 |
| 1644 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19515421 | SHOE SOLE WITH GRAPHENE PROPULSION PLATE | Xtep (China) Co., Ltd. | COLLIER, JAMESON D | 3732 | §102§103§112 | Non-Final OA | — | Pending | Feb 27, 2026 |
| 19055564 | WATER SINK | Xiamen Boma International Trade Co., Ltd. | BAKER, LORI LYNN | 3754 | §103 | Non-Final OA | — | Pending | Feb 18, 2025 |
| 18950225 | FOLDABLE PROTECTIVE COVER | Xiamen Yixin Trading Co., Ltd. | MCFARLAND, KATHLEEN MAVOURNEEN | §103§112 | Non-Final OA | — | Pending | Nov 18, 2024 | |
| 18704949 | LUMINESCENT MATERIAL AND MINI-LED DEVICE PREPARED USING LUMINESCENT MATERIAL | Xiamen University | GROOMS, NOA WILLIAM FRAN | 1734 | §103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18434764 | BEVERAGE CONTAINER AND COVER UNIT | Zhejiang Hasa Science&Technology Co., Ltd. | BETIT, JACOB F | 3735 | §102 | Non-Final OA | 324d overdue | Pending | Feb 06, 2024 |
| 18294174 | CHEMICAL-MECHANICAL COMBINED MACHINING METHOD FOR SILICON CARBIDE SURFACE | Huaqiao University | LU, JIONG-PING | 1713 | §103 | Non-Final OA | 26d | Pending | Feb 01, 2024 |
| 18288197 | SUPER-SOFT COMPOSITE WIPING NON-WOVEN FABRIC AND MANUFACTURING METHOD THEREFOR | Xiamen Yanjan New Material Co., Ltd. | GILLETT, JENNIFER ANN | 1789 | §103§112 | Final Rejection | — | Pending | Oct 25, 2023 |
| 17610458 | KETTLE-TYPE CONTINUOUS PRODUCTION METHOD FOR GLYCINE | Huayang New Material Technology Group Co., Lt | MURESAN, ANA Z | 1692 | §103 | Non-Final OA | — | Pending | Sep 12, 2023 |
| 18275226 | S-RBD Trimer Protein Vaccine for Novel Coronavirus and Preparation Method and Application Therefor | National Vaccine And Serum Institute (Nvsl) | JADHAO, SAMADHAN JAISING | 1672 | §101§103§112 | Final Rejection | 47d | Pending | Aug 01, 2023 |
| 17681855 | Chimeric Antigen Receptor Targeting CD22 and CD19 and Application thereof | Institute Of Hematology And Blood Diseases Hospital, Chinese Academy Of Medical Sciences | PETRASH, HILARY ANN | 1644 | §103§112Other | Final Rejection | 19d | Pending | Feb 28, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial